Gallacher Capital Management LLC Halozyme Therapeutics, Inc. Transaction History
Gallacher Capital Management LLC
- $218 Billion
- Q3 2024
A detailed history of Gallacher Capital Management LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Gallacher Capital Management LLC holds 4,235 shares of HALO stock, worth $236,567. This represents 0.11% of its overall portfolio holdings.
Number of Shares
4,235
Previous 7,166
40.9%
Holding current value
$236,567
Previous $375 Million
35.39%
% of portfolio
0.11%
Previous 0.2%
Shares
5 transactions
Others Institutions Holding HALO
# of Institutions
539Shares Held
126MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$984 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$720 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$371 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$227 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$190 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.78B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...